Welcome to the scientific zone of the Merck Frosst Centre for Therapeutic Research site. Here we showcase our Canadian research programs targeting the discovery of new treatments for respiratory and inflammatory diseases, as well as our work in exciting new areas of endocrinology, bone biology and neurodegenerative disorders. We hope that all visiting scientists will enjoy our site. For those looking for the next step in their careers, we would encourage you to check out career opportunities with us. Merck Frosst is always interested in world-class scientists who wish to apply their talents to build on our legacy of success for a healthier tomorrow.
Canadian researchers are at the forefront of many medical discoveries.
Meet some of Canada's best at the Merck Frosst Spotlight on Canadian Researchers page. Dr. Marc Grynpas was one of the developers of a bone substitute that is the main substance used for replacing the small bones of the inner ear. His current research focusses on understanding what mechanisms affect the quality of bone with the goal of developing new therapies to prevent the bone loss caused by osteoporosis. Patent laws protect pharmaceutical products allowing pharmaceutical companies to invest more money into research and development of innovative drug therapies. Take our interactive journey to learn how a new drug moves from the laboratory to the pharmacy.